retatrutide peptide company Buy (Reta) UK 10mg Retatrutide 10mg — Triple Agonist

Retatrutide is an investigational injectable medication currently under clinical development for the treatment of obesity and overweight

Key highlights Retatrutide is a peptide weight loss medication with triple agonism at GLP-1, GIP, and glucagon receptors

From a translational standpoint, catestatin may be more tractable as a pathway biomarker or as a guide for targeting autonomic dysregulation rather than as a direct peptide therapeutic

Any products and informational content displayed on this page are not intended to diagnose, treat, cure, or prevent any disease.

Our research compounds are third-party tested, and products sold online through our store include a batch certificate of analysis for peptide research

We have added it to a list of your favorite stories